The DOI matches its Crossref record.
Human Recombinant Erythropoietin in Asphyxia Neonatorum: Pilot Trial
Abstract
OBJECTIVE: The goal was to examine biochemical, neurophysiologic, anatomic, and clinical changes associated with erythropoietin administration to neonates with hypoxic-ischemic encephalopathy (HIE). METHODS: We conducted a prospective case-control study with 45 neonates in 3 groups, a normal healthy group (N = 15), a HIE-erythropoietin group (N = 15; infants with mild/moderate HIE who received human recombinant erythropoietin, 2500 IU/kg, subcutaneously, daily for 5 days), and a HIE-control group (N = 15; did not receive erythropoietin). Serum concentrations of nitric oxide (NO) were measured at enrollment for the normal healthy neonates and at enrollment and after 2 weeks for the 2 HIE groups. The 2 HIE groups underwent electroencephalography at enrollment and at 2 to 3 weeks. Brain MRI was performed at 3 weeks. Neurologic evaluations and Denver Developmental Screening Test II assessments were performed at 6 months. RESULTS: Compared with normal healthy neonates, the 2 HIE groups had greater blood NO concentrations (P < .001). At enrollment, the 2 HIE groups did not differ in clinical severity, seizure incidence, NO concentrations, or electroencephalographic findings. At 2 weeks of age, electroencephalographic backgrounds improved significantly (P = .01) and NO concentrations decreased (P < .001) in the HIE-erythropoietin group, compared with the HIE-control group; MRI findings did not differ between groups. At 6 months of age, infants in the HIE-erythropoietin group had fewer neurologic (P = .03) and developmental (P = .03) abnormalities. CONCLUSION: This study demonstrates the feasibility of early administration of human recombinant erythropoietin to term neonates with HIE, to protect against encephalopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
Juul, S. E., Comstock, B. A., Wadhawan, R., Mayock, D. E., Courtney, S. E., Robinson, T., Ahmad, K. A., Bendel-Stenzel, E., Baserga, M., LaGamma, E. F., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1907423 · Cited by 325
Hypoxic Ischemic Encephalopathy: Pathophysiology and Experimental Treatments
Allen, K. A., & Brandon, D. H. (2011) · Newborn and Infant Nursing Reviews · doi:10.1053/j.nainr.2011.07.004 · Cited by 295
Treatment advances in neonatal neuroprotection and neurointensive care
Johnston, M. V., Fatemi, A., Wilson, M. A., & Northington, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70016-3 · Cited by 278
Infection-induced inflammation and cerebral injury in preterm infants
Strunk, T., Inder, T., Wang, X., Burgner, D., Mallard, C., & Levy, O. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70710-8 · Cited by 269
Drugs for neuroprotection after birth asphyxia: Pharmacologic adjuncts to hypothermia
Bel, F. V., & Groenendaal, F. (2016) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.12.003 · Cited by 58
Metadata
- Authors
- Elmahdy, H., El-Mashad, A.-R., El-Bahrawy, H., El-Gohary, T., El-Barbary, A., & Aly, H.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2010-05-01
- Volume
- 125
- Issue
- 5
- Pages
- e1135-e1142
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2139878559
- Cited by
- 198
- References
- 0
- FWCI
- 13.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human Recombinant Erythropoietin in Asphyxia Neonatorum: Pilot Trial. https://app.cochat.ai/papers/10.1542/peds.2009-2268
- The paper
- Elmahdy, H., El-Mashad, A.-R., El-Bahrawy, H., El-Gohary, T., El-Barbary, A., & Aly, H. (2010). Human Recombinant Erythropoietin in Asphyxia Neonatorum: Pilot Trial. Pediatrics. https://doi.org/10.1542/peds.2009-2268
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.